Obaro S Michael
Overview
Explore the profile of Obaro S Michael including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Orimadegun A, Dada-Adegbola H, Michael O, Adepoju A, Funwei R, Olusola F, et al.
Ann Afr Med
. 2024 Feb;
22(4):470-480.
PMID: 38358148
Context And Aim: Given the challenges of microscopy, we compared its performance with SD-Bioline malaria rapid diagnostic test (MRDT) and polymerase chain reaction (PCR) and evaluated the time it took...
2.
Falade C, Orimadegun A, Olusola F, Michael O, Anjorin O, Funwei R, et al.
Malar J
. 2023 May;
22(1):154.
PMID: 37179349
Background: In Nigeria, declining responsiveness to artemether-lumefantrine (AL), the artemisinin-based combination therapy (ACT) of choice since 2005, has been reported. Pyronaridine-artesunate (PA) is a newer fixed-dose ACT recently prequalified by...
3.
Adeoye A, Adebusoye L, Fakunle A, Aderonmu O, Adebayo O, Michael O, et al.
Niger Postgrad Med J
. 2022 Jul;
29(3):206-213.
PMID: 35900456
Background: Hypertension is the largest contributor to the global burden of disease. Emerging risk factors for cardiovascular disease include blood pressure variability (BPV), but evidence on BPV is lacking among...
4.
Orimadegun A, Dada-Adegbola H, Michael O, Adepoju A, Funwei R, Olusola F, et al.
J Trop Pediatr
. 2022 Jul;
68(4).
PMID: 35895093
Background: Although the global malaria burden is decreasing, there are still concerns about overdiagnosis of malaria and the danger of misdiagnosis of non-malaria causes of fever. Clinicians continue to face...
5.
Adetunji A, Adewumi M, Michael O, Fayemiwo S, Ogunniyi A, Taiwo B
Am J Trop Med Hyg
. 2019 Jun;
101(2):285-286.
PMID: 31162006
Detection of acute HIV infection is a unique problem that fourth-generation HIV assays were expected to alleviate. In this commentary, we draw attention to the limitations and challenges with use...
6.
7.
Gbotosho G, Sowunmi A, Okuboyejo T, Happi C, Folarin O, Michael O, et al.
Am J Trop Med Hyg
. 2011 May;
84(5):813-9.
PMID: 21540395
The therapeutic efficacy and effects of artemether-lumefantrine (AL) and artesunate-amodiaquine co-formulated (AAcf) or co-packaged (AAcp) on malaria-associated anemia (MAA) were evaluated in 285 children < 12 years of age with...
8.
Sowunmi A, Gbotosho G, Happi C, Okuboyejo T, Sijuade A, Michael O, et al.
Am J Ther
. 2010 Dec;
20(1):48-56.
PMID: 21192244
The treatment efficacy of artesunate-amodiaquine (AQ) coformulated or copackaged, and the plasma and saliva concentrations of desethylamodiaquine (DEAQ), the active metabolite of AQ, were evaluated in 120 and 7 children,...
9.
Michael O, Gbotosho G, Folarin O, Okuboyejo T, Sowunmi A, Oduola A, et al.
Malar J
. 2010 Nov;
9:335.
PMID: 21092220
Background: Combination treatments, preferably containing an artemisinin derivative, are recommended to improve efficacy and prevent Plasmodium falciparum drug resistance. Artemether-lumefantrine (AL) and artesunate-amodiaquine (AA) are efficacious regimens that have been...
10.
Sowunmi A, Adewoye E, Gbotsho G, Happi C, Sijuade A, Folarin O, et al.
Malar J
. 2010 Feb;
9:53.
PMID: 20156350
Background: Drug resistance in Plasmodium falciparum is common in many endemic and other settings but there is no clear recommendation on when to change therapy when there is delay in...